BFIC
ABBV icon

Bedell Frazier Investment Counselling’s AbbVie ABBV Stock Holding History

Bedell Frazier Investment Counselling’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$518K Sell
2,384
-74
-3% -$16.4K 0.1% 86
2025
Q4 		$562K Buy
2,458
+569
+30% +$130K 0.11% 88
2025
Q3 		$437K Sell
1,889
-50
-3% -$10.2K 0.09% 93
2025
Q2 		$360K Hold
1,939
– – 0.09% 86
2025
Q1 		$406K Sell
1,939
-40
-2% -$7.78K 0.1% 77
2024
Q4 		$352K Sell
1,979
-185
-9% -$34K 0.09% 90
2024
Q3 		$427K Sell
2,164
-10
-0.5% -$1.87K 0.1% 83
2024
Q2 		$373K Sell
2,174
-1,295
-37% -$215K 0.09% 85
2024
Q1 		$632K Sell
3,469
-67,230
-95% -$11.6M 0.16% 71
2023
Q4 		$11M Buy
70,699
+3,321
+5% +$484K 3.01% 8
2023
Q3 		$10M Buy
67,378
+1,847
+3% +$271K 3% 9
2023
Q2 		$8.83M Buy
65,531
+3,381
+5% +$496K 2.58% 10
2023
Q1 		$9.9M Buy
62,150
+1,669
+3% +$255K 2.9% 10
2022
Q4 		$9.77M Sell
60,481
-1,526
-2% -$234K 2.56% 11
2022
Q3 		$8.32M Buy
62,007
+197
+0.3% +$28.3K 2.34% 12
2022
Q2 		$9.47M Buy
61,810
+635
+1% +$97K 2.91% 9
2022
Q1 		$9.92M Sell
61,175
-13,440
-18% -$1.95M 2.51% 9
2021
Q4 		$10.1M Buy
74,615
+1,731
+2% +$204K 2.46% 9
2021
Q3 		$7.86M Buy
72,884
+3,179
+5% +$363K 2.16% 14
2021
Q2 		$7.85M Buy
69,705
+4,876
+8% +$549K 1.99% 18
2021
Q1 		$7.02M Buy
64,829
+2,926
+5% +$313K 1.98% 20
2020
Q4 		$6.63M Buy
61,903
+830
+1% +$79.8K 2.03% 18
2020
Q3 		$5.35M Sell
61,073
-40,457
-40% -$3.81M 1.91% 22
2020
Q2 		$9.97M Sell
101,530
-6,795
-6% -$598K 4.02% 6
2020
Q1 		$8.25M Buy
108,325
+15,625
+17% +$1.33M 3.87% 9
2019
Q4 		$7.02M Hold
92,700
– – 2.81% 12
2019
Q3 		$7.02M Sell
92,700
-11,525
-11% -$790K 2.74% 12
2019
Q2 		$7.58M Buy
104,225
+3,075
+3% +$242K 2.76% 16
2019
Q1 		$8.15M Buy
101,150
+8,950
+10% +$732K 3.22% 11
2018
Q4 		$8.5M Buy
92,200
+8,725
+10% +$767K 3.61% 8
2018
Q3 		$7.89M Buy
+83,475
New +$7.92M 2.19% 24
2018
Q1 		– Sell
-2,125
Closed -$205K – 49
2017
Q4 		$205K Sell
2,125
-80,783
-97% -$7.61M 0.08% 49
2017
Q3 		$7.37M Sell
82,908
-9,562
-10% -$728K 3.4% 12
2017
Q2 		$6.71M Sell
92,470
-85
-0.1% -$5.71K 2.45% 19
2017
Q1 		$6.03M Buy
92,555
+9,160
+11% +$576K 2.29% 24
2016
Q4 		$5.22M Buy
83,395
+2,715
+3% +$166K 2.05% 22
2016
Q3 		$5.09M Sell
80,680
-335
-0.4% -$21.7K 2.11% 23
2016
Q2 		$4.88M Sell
81,015
-90,316
-53% -$5.5M 2.41% 20
2016
Q1 		$9.79M Buy
171,331
+8,415
+5% +$469K 5.05% 3
2015
Q4 		$9.65M Buy
162,916
+67,730
+71% +$3.9M 4.79% 5
2015
Q3 		$5.18M Sell
95,186
-1,165
-1% -$75.8K 2.99% 12
2015
Q2 		$6.47M Buy
96,351
+2,765
+3% +$181K 2.57% 10
2015
Q1 		$5.48M Buy
+93,586
New +$5.65M 2.27% 16

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bedell Frazier Investment Counselling's ABBV Position: Q1 2026 in Review

Bedell Frazier Investment Counselling reduced its AbbVie (ABBV) stake by 3% in Q1 2026, selling an estimated $16.4K and leaving 2,384 shares worth $518K. The position accounts for 0.1% of the portfolio, ranked #86.

Bedell Frazier Investment Counselling first reported a position in ABBV in Q1 2015 and has held it in 43 quarters since. The position peaked at $11M in Q4 2023. 4,090 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Bedell Frazier Investment Counselling held 2,384 shares of AbbVie worth $518K as of Q1 2026.
  • Bedell Frazier Investment Counselling sold 74 AbbVie shares in Q1 2026, an estimated $16.4K.
  • AbbVie made up 0.1% of Bedell Frazier Investment Counselling's portfolio in Q1 2026, its #86 holding.
  • Bedell Frazier Investment Counselling first reported a position in AbbVie in Q1 2015 and has held it in 43 quarters since.
  • Bedell Frazier Investment Counselling's AbbVie position peaked at $11M in Q4 2023.
  • 4,090 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bedell Frazier Investment Counselling's 13F filing for Q1 2026, filed 15 May 2026.